LMX 250 Capsule is a combination antibiotic formulation containing Amoxycillin 250 mg and Lactobacillus 1700 million spores per capsule. Amoxycillin, a broad-spectrum beta-lactam antibiotic, is effective against a wide range of Gram-positive and Gram-negative bacterial infections by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media. The inclusion of Lactobacillus, a probiotic strain, helps maintain and restore the natural balance of gut flora during and after antibiotic therapy, thereby reducing the risk of antibiotic-associated diarrhea and other gastrointestinal disturbances. LMX 250 Capsule is indicated for patients requiring moderate-dose amoxycillin treatment alongside probiotic support to enhance gastrointestinal health. The combination ensures effective bacterial eradication while minimizing disruption to the intestinal microbiota. It should be administered as directed by a healthcare professional, with dosage adjustments based on the severity of infection and patient-specific factors. Caution is advised in patients with a history of penicillin allergy. Common side effects may include mild gastrointestinal discomfort, nausea, or allergic reactions. This product is contraindicated in individuals with hypersensitivity to beta-lactam antibiotics.